Int J Vitam Nutr Res, DOI: 10.1024/0300-9831.75.2.156 Molfino, A., Cascino, A., Conte, C., Ramaccini, C., Fanelli, F
It is caused by either lack of intrinsic factors or surgical removal of parts of the digestive system that bypass the small intestine
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial. Diabetes Care, vol
For a broader comparison of compounded vs branded GLP-1 options, see our detailed semaglutide vs tirzepatide comparison and our guide on compounded semaglutide
Factors such as BMI, overall health, and existing medical conditions will be considered to ensure safety and appropriateness